var eventsData = [{"Ticker":"AKAM","EffectiveDate":"2017-02-07","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2016 Q4's earning $0.72 per share and revenue $616.124MM. This beats analyst's estimated EPS $0.68, beats estimated revenue $605.19MM.","DailyReturn":0.020227,"FiveDayReturnAfter":null,"FiveDayReturnBefore":0.027633},{"Ticker":"AKAM","EffectiveDate":"2016-12-22","Type":"RatingNeutral","Title":"Guggenheim initiates coverage on AKAM to Buy. Target Price is $75.","DailyReturn":-0.007367,"FiveDayReturnAfter":-0.012304,"FiveDayReturnBefore":0.013049},{"Ticker":"AKAM","EffectiveDate":"2016-12-14","Type":"RatingUpgrade","Title":"Oppenheimer upgrades AKAM to Outperform from Perform. Target Price is $70; previously $65.","DailyReturn":0.0284,"FiveDayReturnAfter":0.053208,"FiveDayReturnBefore":0.00323},{"Ticker":"AKAM","EffectiveDate":"2016-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010789,"FiveDayReturnAfter":-0.005486,"FiveDayReturnBefore":-0.060437},{"Ticker":"AKAM","EffectiveDate":"2016-11-07","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.010789,"FiveDayReturnAfter":-0.005486,"FiveDayReturnBefore":-0.060437},{"Ticker":"AKAM","EffectiveDate":"2016-10-26","Type":"RatingUpgrade","Title":"FBR Capital upgrades AKAM to Market Perform from Underperform.","DailyReturn":0.146098,"FiveDayReturnAfter":0.142254,"FiveDayReturnBefore":0.054801},{"Ticker":"AKAM","EffectiveDate":"2016-10-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003909,"FiveDayReturnAfter":0.166073,"FiveDayReturnBefore":0.068581},{"Ticker":"AKAM","EffectiveDate":"2016-10-25","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2016 Q3's earning $0.68 per share and revenue $584.065MM. This beats analyst's estimated EPS $0.61, beats estimated revenue $571.92MM.","DailyReturn":0.003909,"FiveDayReturnAfter":0.166073,"FiveDayReturnBefore":0.068581},{"Ticker":"AKAM","EffectiveDate":"2016-10-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.003909,"FiveDayReturnAfter":0.166073,"FiveDayReturnBefore":0.068581},{"Ticker":"AKAM","EffectiveDate":"2016-08-12","Type":"RatingUpgrade","Title":"Wells Fargo upgrades AKAM to Outperform from Market Perform.","DailyReturn":0.010893,"FiveDayReturnAfter":0.018119,"FiveDayReturnBefore":0.039275},{"Ticker":"AKAM","EffectiveDate":"2016-08-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.035842,"FiveDayReturnAfter":0.034831,"FiveDayReturnBefore":0.00519},{"Ticker":"AKAM","EffectiveDate":"2016-08-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.035842,"FiveDayReturnAfter":0.034831,"FiveDayReturnBefore":0.00519},{"Ticker":"AKAM","EffectiveDate":"2016-07-27","Type":"RatingNeutral","Title":"Pacific Crest downgrades AKAM to Sector Weight from Overweight.","DailyReturn":-0.130487,"FiveDayReturnAfter":-0.15077,"FiveDayReturnBefore":0.011078},{"Ticker":"AKAM","EffectiveDate":"2016-07-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains AKAM to Sell. Target Price is $47; previously $43.","DailyReturn":-0.130487,"FiveDayReturnAfter":-0.15077,"FiveDayReturnBefore":0.011078},{"Ticker":"AKAM","EffectiveDate":"2016-07-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.003281,"FiveDayReturnAfter":-0.134765,"FiveDayReturnBefore":0.007454},{"Ticker":"AKAM","EffectiveDate":"2016-07-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003281,"FiveDayReturnAfter":-0.134765,"FiveDayReturnBefore":0.007454},{"Ticker":"AKAM","EffectiveDate":"2016-07-26","Type":"RevenueBeat","Title":"After market close, AKAM reports 2016 Q2's earning $0.64 per share and revenue $572.135MM. This meets analyst's estimated EPS $0.64, misses estimated revenue $574.86MM.","DailyReturn":0.003281,"FiveDayReturnAfter":-0.134765,"FiveDayReturnBefore":0.007454},{"Ticker":"AKAM","EffectiveDate":"2016-07-21","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on AKAM to Buy. Target Price is $66.","DailyReturn":-0.010894,"FiveDayReturnAfter":-0.135336,"FiveDayReturnBefore":0.016916},{"Ticker":"AKAM","EffectiveDate":"2016-05-11","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.024052,"FiveDayReturnAfter":-0.01943,"FiveDayReturnBefore":0.040445},{"Ticker":"AKAM","EffectiveDate":"2016-04-27","Type":"RatingNeutral","Title":"Baird maintains AKAM to Outperform. Target Price is $60; previously $62.","DailyReturn":0.041588,"FiveDayReturnAfter":-0.053635,"FiveDayReturnBefore":0.025191},{"Ticker":"AKAM","EffectiveDate":"2016-04-27","Type":"RatingNeutral","Title":"Craig-Hallum downgrades AKAM to Hold from Buy.","DailyReturn":0.041588,"FiveDayReturnAfter":-0.053635,"FiveDayReturnBefore":0.025191},{"Ticker":"AKAM","EffectiveDate":"2016-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.03073,"FiveDayReturnAfter":-0.002941,"FiveDayReturnBefore":-0.012836},{"Ticker":"AKAM","EffectiveDate":"2016-04-26","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2016 Q1's earning $0.66 per share and revenue $567.725MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $563.81MM.","DailyReturn":0.03073,"FiveDayReturnAfter":-0.002941,"FiveDayReturnBefore":-0.012836},{"Ticker":"AKAM","EffectiveDate":"2016-04-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.03073,"FiveDayReturnAfter":-0.002941,"FiveDayReturnBefore":-0.012836},{"Ticker":"AKAM","EffectiveDate":"2016-03-24","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on AKAM to Hold.","DailyReturn":-0.00508,"FiveDayReturnAfter":0.008132,"FiveDayReturnBefore":-0.012441},{"Ticker":"AKAM","EffectiveDate":"2016-03-24","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on AKAM to Sector Perform. Target Price is $62.","DailyReturn":-0.00508,"FiveDayReturnAfter":0.008132,"FiveDayReturnBefore":-0.012441},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Credit Suisse assumes AKAM to Neutral. Target Price is $45.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"UBS maintains AKAM to Buy. Target Price is $55; previously $65.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"KeyBanc maintains AKAM to Outperform. Target Price is $71; previously $75.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Deutsche Bank maintains AKAM to Buy. Target Price is $75; previously $80.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingUpgrade","Title":"Craig-Hallum upgrades AKAM to Buy.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingUpgrade","Title":"B. Riley upgrades AKAM to Buy.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Neutral. Target Price is $60; previously $65.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"FBR Capital maintains AKAM to Underperform. Target Price is $42; previously $49.","DailyReturn":0.212029,"FiveDayReturnAfter":0.300113,"FiveDayReturnBefore":-0.081733},{"Ticker":"AKAM","EffectiveDate":"2016-02-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.034407,"FiveDayReturnAfter":0.24868,"FiveDayReturnBefore":-0.100223},{"Ticker":"AKAM","EffectiveDate":"2016-02-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.034407,"FiveDayReturnAfter":0.24868,"FiveDayReturnBefore":-0.100223},{"Ticker":"AKAM","EffectiveDate":"2016-02-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.033768,"FiveDayReturnAfter":-0.081733,"FiveDayReturnBefore":-0.073175},{"Ticker":"AKAM","EffectiveDate":"2016-02-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.033768,"FiveDayReturnAfter":-0.081733,"FiveDayReturnBefore":-0.073175},{"Ticker":"AKAM","EffectiveDate":"2016-01-11","Type":"RatingNeutral","Title":"Pacific Crest maintains AKAM to Outperform. Target Price is $75; previously $86.","DailyReturn":-0.054886,"FiveDayReturnAfter":-0.085691,"FiveDayReturnBefore":-0.090005},{"Ticker":"AKAM","EffectiveDate":"2016-01-11","Type":"RatingNeutral","Title":"KeyBanc maintains AKAM to Outperform. Target Price is $75; previously $86.","DailyReturn":-0.054886,"FiveDayReturnAfter":-0.085691,"FiveDayReturnBefore":-0.090005},{"Ticker":"AKAM","EffectiveDate":"2015-12-14","Type":"RatingNeutral","Title":"Evercore ISI Group initiates coverage on AKAM to Buy. Target Price is $70.","DailyReturn":-0.01409,"FiveDayReturnAfter":0.009795,"FiveDayReturnBefore":-0.088779},{"Ticker":"AKAM","EffectiveDate":"2015-11-20","Type":"RatingNeutral","Title":"Goldman Sachs downgrades AKAM to Sell from Neutral. Target Price is $52; previously $62.","DailyReturn":-0.038676,"FiveDayReturnAfter":-0.022374,"FiveDayReturnBefore":-0.020561},{"Ticker":"AKAM","EffectiveDate":"2015-11-12","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.015956,"FiveDayReturnAfter":-0.035971,"FiveDayReturnBefore":-0.01294},{"Ticker":"AKAM","EffectiveDate":"2015-11-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.015956,"FiveDayReturnAfter":-0.035971,"FiveDayReturnBefore":-0.01294},{"Ticker":"AKAM","EffectiveDate":"2015-11-03","Type":"RatingNeutral","Title":"Macquarie maintains AKAM to Neutral. Target Price is $65; previously $71.","DailyReturn":0.021528,"FiveDayReturnAfter":0.000811,"FiveDayReturnBefore":-0.198829},{"Ticker":"AKAM","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"FBR Capital downgrades AKAM to Underperform.","DailyReturn":-0.028612,"FiveDayReturnAfter":-0.011027,"FiveDayReturnBefore":-0.123225},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Craig-Hallum downgrades AKAM to Hold from Buy.","DailyReturn":-0.167306,"FiveDayReturnAfter":-0.179914,"FiveDayReturnBefore":0.049241},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Canaccord Genuity downgrades AKAM to Hold. Target Price is $65.","DailyReturn":-0.167306,"FiveDayReturnAfter":-0.179914,"FiveDayReturnBefore":0.049241},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Pacific Crest maintains AKAM to Overweight. Target Price is $86; previously $91.","DailyReturn":-0.167306,"FiveDayReturnAfter":-0.179914,"FiveDayReturnBefore":0.049241},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Morgan Stanley maintains AKAM to Equal-Weight. Target Price is $70; previously $75.","DailyReturn":-0.167306,"FiveDayReturnAfter":-0.179914,"FiveDayReturnBefore":0.049241},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"JP Morgan downgrades AKAM to Neutral from Overweight. Target Price is $65; previously $75.","DailyReturn":-0.167306,"FiveDayReturnAfter":-0.179914,"FiveDayReturnBefore":0.049241},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"B. Riley maintains AKAM to Neutral. Target Price is $64; previously $66.","DailyReturn":-0.167306,"FiveDayReturnAfter":-0.179914,"FiveDayReturnBefore":0.049241},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Cowen & Co. downgrades AKAM to Market Perform from Outperform.","DailyReturn":-0.167306,"FiveDayReturnAfter":-0.179914,"FiveDayReturnBefore":0.049241},{"Ticker":"AKAM","EffectiveDate":"2015-10-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.002388,"FiveDayReturnAfter":-0.198829,"FiveDayReturnBefore":0.067933},{"Ticker":"AKAM","EffectiveDate":"2015-10-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.002388,"FiveDayReturnAfter":-0.198829,"FiveDayReturnBefore":0.067933},{"Ticker":"AKAM","EffectiveDate":"2015-08-31","Type":"RatingNeutral","Title":"Deutsche Bank maintains AKAM to Buy. Target Price is $80; previously $77.","DailyReturn":-0.008206,"FiveDayReturnAfter":0.009413,"FiveDayReturnBefore":0.055181},{"Ticker":"AKAM","EffectiveDate":"2015-08-28","Type":"RatingUpgrade","Title":"JMP Securities upgrades AKAM to Market Outperform from Market Perform. Target Price is $85.","DailyReturn":0.019858,"FiveDayReturnAfter":0.038401,"FiveDayReturnBefore":0.010267},{"Ticker":"AKAM","EffectiveDate":"2015-08-20","Type":"RatingNeutral","Title":"Pacific Crest assumes AKAM to Overweight. Target Price is $91.","DailyReturn":-0.044895,"FiveDayReturnAfter":-0.069275,"FiveDayReturnBefore":-0.011702},{"Ticker":"AKAM","EffectiveDate":"2015-07-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.028201,"FiveDayReturnAfter":0.055926,"FiveDayReturnBefore":-0.0255},{"Ticker":"AKAM","EffectiveDate":"2015-07-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.028201,"FiveDayReturnAfter":0.055926,"FiveDayReturnBefore":-0.0255},{"Ticker":"AKAM","EffectiveDate":"2015-07-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.012657,"FiveDayReturnAfter":-0.0255,"FiveDayReturnBefore":0.024941},{"Ticker":"AKAM","EffectiveDate":"2015-07-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.012657,"FiveDayReturnAfter":-0.0255,"FiveDayReturnBefore":0.024941},{"Ticker":"AKAM","EffectiveDate":"2015-07-09","Type":"RatingNeutral","Title":"Deutsche Bank maintains AKAM to Buy. Target Price is $77; previously $79.","DailyReturn":0.00639,"FiveDayReturnAfter":0.045424,"FiveDayReturnBefore":-0.013846},{"Ticker":"AKAM","EffectiveDate":"2015-06-09","Type":"RatingNeutral","Title":"Macquarie initiates coverage on AKAM to Outperform. Target Price is $75; previously $77.","DailyReturn":-0.026572,"FiveDayReturnAfter":-0.032434,"FiveDayReturnBefore":-0.004531},{"Ticker":"AKAM","EffectiveDate":"2015-05-19","Type":"RatingNeutral","Title":"UBS maintains AKAM to Buy. Target Price is $88; previously $79.","DailyReturn":-0.008211,"FiveDayReturnAfter":-0.013042,"FiveDayReturnBefore":0.02389},{"Ticker":"AKAM","EffectiveDate":"2015-05-19","Type":"RatingNeutral","Title":"Oppenheimer downgrades AKAM to Perform from Outperform.","DailyReturn":-0.008211,"FiveDayReturnAfter":-0.013042,"FiveDayReturnBefore":0.02389},{"Ticker":"AKAM","EffectiveDate":"2015-05-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.001974,"FiveDayReturnAfter":0.017354,"FiveDayReturnBefore":0.008062},{"Ticker":"AKAM","EffectiveDate":"2015-05-13","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.001974,"FiveDayReturnAfter":0.017354,"FiveDayReturnBefore":0.008062},{"Ticker":"AKAM","EffectiveDate":"2015-05-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.001974,"FiveDayReturnAfter":0.017354,"FiveDayReturnBefore":0.008062},{"Ticker":"AKAM","EffectiveDate":"2015-04-29","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Overweight. Target Price is $75; previously $73.","DailyReturn":-0.012357,"FiveDayReturnAfter":-0.009378,"FiveDayReturnBefore":0.010175},{"Ticker":"AKAM","EffectiveDate":"2015-04-29","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades AKAM to Buy from Hold.","DailyReturn":-0.012357,"FiveDayReturnAfter":-0.009378,"FiveDayReturnBefore":0.010175},{"Ticker":"AKAM","EffectiveDate":"2015-04-29","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Buy. Target Price is $78; previously $75.","DailyReturn":-0.012357,"FiveDayReturnAfter":-0.009378,"FiveDayReturnBefore":0.010175},{"Ticker":"AKAM","EffectiveDate":"2015-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.012591,"FiveDayReturnAfter":-0.025505,"FiveDayReturnBefore":0.047585},{"Ticker":"AKAM","EffectiveDate":"2015-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.012591,"FiveDayReturnAfter":-0.025505,"FiveDayReturnBefore":0.047585},{"Ticker":"AKAM","EffectiveDate":"2015-04-09","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on AKAM to Hold. Target Price is $73.","DailyReturn":-0.007383,"FiveDayReturnAfter":-0.00629,"FiveDayReturnBefore":0.01036},{"Ticker":"AKAM","EffectiveDate":"2015-02-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.020505,"FiveDayReturnAfter":0.143408,"FiveDayReturnBefore":0.041362},{"Ticker":"AKAM","EffectiveDate":"2015-02-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.020505,"FiveDayReturnAfter":0.143408,"FiveDayReturnBefore":0.041362},{"Ticker":"AKAM","EffectiveDate":"2015-02-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.002828,"FiveDayReturnAfter":0.034173,"FiveDayReturnBefore":-0.002823},{"Ticker":"AKAM","EffectiveDate":"2015-02-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.002828,"FiveDayReturnAfter":0.034173,"FiveDayReturnBefore":-0.002823},{"Ticker":"AKAM","EffectiveDate":"2015-01-09","Type":"RatingNeutral","Title":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $69; previously $70.","DailyReturn":-0.012831,"FiveDayReturnAfter":-0.048929,"FiveDayReturnBefore":-0.022324},{"Ticker":"AKAM","EffectiveDate":"2014-12-30","Type":"RatingNeutral","Title":"DA Davidson maintains AKAM to Buy. Target Price is $86; previously $72.","DailyReturn":0.004389,"FiveDayReturnAfter":-0.050148,"FiveDayReturnBefore":0.009292},{"Ticker":"AKAM","EffectiveDate":"2014-11-17","Type":"RatingNeutral","Title":"JMP Securities initiates coverage on AKAM to Market Perform.","DailyReturn":-0.014302,"FiveDayReturnAfter":0.012633,"FiveDayReturnBefore":0.045348},{"Ticker":"AKAM","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Credit Suisse maintains AKAM to Neutral. Target Price is $52.5; previously $50.","DailyReturn":0.064401,"FiveDayReturnAfter":0.04878,"FiveDayReturnBefore":0.041038},{"Ticker":"AKAM","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.016448,"FiveDayReturnAfter":0.042478,"FiveDayReturnBefore":0.038166},{"Ticker":"AKAM","EffectiveDate":"2014-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.016448,"FiveDayReturnAfter":0.042478,"FiveDayReturnBefore":0.038166},{"Ticker":"AKAM","EffectiveDate":"2014-10-22","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.019269,"FiveDayReturnAfter":0.038166,"FiveDayReturnBefore":-0.011568},{"Ticker":"AKAM","EffectiveDate":"2014-10-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.019269,"FiveDayReturnAfter":0.038166,"FiveDayReturnBefore":-0.011568},{"Ticker":"AKAM","EffectiveDate":"2014-09-05","Type":"RatingNeutral","Title":"UBS initiates coverage on AKAM to Buy. Target Price is $70.","DailyReturn":0.018537,"FiveDayReturnAfter":0.030963,"FiveDayReturnBefore":-0.001324},{"Ticker":"AKAM","EffectiveDate":"2014-08-27","Type":"RatingNeutral","Title":"Baird initiates coverage on AKAM to Outperform. Target Price is $71.","DailyReturn":-0.000991,"FiveDayReturnAfter":-0.003143,"FiveDayReturnBefore":-0.005435},{"Ticker":"AKAM","EffectiveDate":"2014-07-31","Type":"RatingNeutral","Title":"Credit Suisse maintains AKAM to Neutral. Target Price is $50; previously $47.5.","DailyReturn":-0.028157,"FiveDayReturnAfter":-0.07149,"FiveDayReturnBefore":0.037582},{"Ticker":"AKAM","EffectiveDate":"2014-07-31","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Overweight. Target Price is $73; previously $67.5.","DailyReturn":-0.028157,"FiveDayReturnAfter":-0.07149,"FiveDayReturnBefore":0.037582},{"Ticker":"AKAM","EffectiveDate":"2014-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.029322,"FiveDayReturnAfter":-0.036946,"FiveDayReturnBefore":0.001357},{"Ticker":"AKAM","EffectiveDate":"2014-07-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.029322,"FiveDayReturnAfter":-0.036946,"FiveDayReturnBefore":0.001357},{"Ticker":"AKAM","EffectiveDate":"2014-07-24","Type":"RatingUpgrade","Title":"Macquarie upgrades AKAM to Outperform from Neutral. Target Price is $70; previously $59.","DailyReturn":0.022397,"FiveDayReturnAfter":0.037582,"FiveDayReturnBefore":-0.010544},{"Ticker":"AKAM","EffectiveDate":"2014-05-14","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.014259,"FiveDayReturnAfter":-0.020089,"FiveDayReturnBefore":0.017031},{"Ticker":"AKAM","EffectiveDate":"2014-05-14","Type":"RatingUpgrade","Title":"Pacific Crest upgrades AKAM to Outperform from Sector Perform. Target Price is $65.","DailyReturn":0.014259,"FiveDayReturnAfter":-0.020089,"FiveDayReturnBefore":0.017031},{"Ticker":"AKAM","EffectiveDate":"2014-05-14","Type":"RatingNeutral","Title":"B. Riley maintains AKAM to Buy. Target Price is $68.","DailyReturn":0.014259,"FiveDayReturnAfter":-0.020089,"FiveDayReturnBefore":0.017031},{"Ticker":"AKAM","EffectiveDate":"2014-05-02","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $54; previously $52.","DailyReturn":-0.024757,"FiveDayReturnAfter":-0.043477,"FiveDayReturnBefore":0.021877},{"Ticker":"AKAM","EffectiveDate":"2014-05-02","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Overweight. Target Price is $67.5; previously $63.","DailyReturn":-0.024757,"FiveDayReturnAfter":-0.043477,"FiveDayReturnBefore":0.021877},{"Ticker":"AKAM","EffectiveDate":"2014-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.027511,"FiveDayReturnAfter":-0.023064,"FiveDayReturnBefore":-0.013104},{"Ticker":"AKAM","EffectiveDate":"2014-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.027511,"FiveDayReturnAfter":-0.023064,"FiveDayReturnBefore":-0.013104},{"Ticker":"AKAM","EffectiveDate":"2014-04-10","Type":"RatingUpgrade","Title":"B. Riley upgrades AKAM to Buy from Neutral. Target Price is $68; previously $52.","DailyReturn":-0.041682,"FiveDayReturnAfter":-0.012033,"FiveDayReturnBefore":-0.05294},{"Ticker":"AKAM","EffectiveDate":"2014-02-18","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.009828,"FiveDayReturnAfter":0.042559,"FiveDayReturnBefore":0.058129},{"Ticker":"AKAM","EffectiveDate":"2014-02-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.009828,"FiveDayReturnAfter":0.042559,"FiveDayReturnBefore":0.058129},{"Ticker":"AKAM","EffectiveDate":"2014-02-18","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":0.009828,"FiveDayReturnAfter":0.042559,"FiveDayReturnBefore":0.058129},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.009638,"FiveDayReturnAfter":0.039942,"FiveDayReturnBefore":0.220863},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.009638,"FiveDayReturnAfter":0.039942,"FiveDayReturnBefore":0.220863},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":0.009638,"FiveDayReturnAfter":0.039942,"FiveDayReturnBefore":0.220863},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.009638,"FiveDayReturnAfter":0.039942,"FiveDayReturnBefore":0.220863},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.009638,"FiveDayReturnAfter":0.039942,"FiveDayReturnBefore":0.220863},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010871,"FiveDayReturnAfter":0.012135,"FiveDayReturnBefore":0.251601},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.010871,"FiveDayReturnAfter":0.012135,"FiveDayReturnBefore":0.251601},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.010871,"FiveDayReturnAfter":0.012135,"FiveDayReturnBefore":0.251601},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010871,"FiveDayReturnAfter":0.012135,"FiveDayReturnBefore":0.251601},{"Ticker":"AKAM","EffectiveDate":"2014-02-07","Type":"RatingNeutral","Title":"DA Davidson maintains AKAM to Buy. Target Price is $63; previously $62.","DailyReturn":-0.009444,"FiveDayReturnAfter":0.043295,"FiveDayReturnBefore":0.16526},{"Ticker":"AKAM","EffectiveDate":"2014-02-05","Type":"RatingUpgrade","Title":"Credit Suisse upgrades AKAM to Neutral from Underperform.","DailyReturn":0.020004,"FiveDayReturnAfter":0.251601,"FiveDayReturnBefore":-0.039228},{"Ticker":"AKAM","EffectiveDate":"2014-02-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.020004,"FiveDayReturnAfter":0.251601,"FiveDayReturnBefore":-0.039228},{"Ticker":"AKAM","EffectiveDate":"2014-02-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.020004,"FiveDayReturnAfter":0.251601,"FiveDayReturnBefore":-0.039228},{"Ticker":"AKAM","EffectiveDate":"2014-01-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.016299,"FiveDayReturnAfter":0.16526,"FiveDayReturnBefore":-0.023247},{"Ticker":"AKAM","EffectiveDate":"2014-01-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.016299,"FiveDayReturnAfter":0.16526,"FiveDayReturnBefore":-0.023247},{"Ticker":"AKAM","EffectiveDate":"2013-12-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.01364,"FiveDayReturnAfter":0.005129,"FiveDayReturnBefore":0.006057},{"Ticker":"AKAM","EffectiveDate":"2013-12-02","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.01364,"FiveDayReturnAfter":0.005129,"FiveDayReturnBefore":0.006057},{"Ticker":"AKAM","EffectiveDate":"2013-11-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.017761,"FiveDayReturnAfter":0.037291,"FiveDayReturnBefore":-0.006276},{"Ticker":"AKAM","EffectiveDate":"2013-11-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.017761,"FiveDayReturnAfter":0.037291,"FiveDayReturnBefore":-0.006276},{"Ticker":"AKAM","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $45.","DailyReturn":-0.112011,"FiveDayReturnAfter":-0.129931,"FiveDayReturnBefore":0.001158},{"Ticker":"AKAM","EffectiveDate":"2013-10-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.02847,"FiveDayReturnAfter":-0.136668,"FiveDayReturnBefore":0.039739},{"Ticker":"AKAM","EffectiveDate":"2013-10-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.02847,"FiveDayReturnAfter":-0.136668,"FiveDayReturnBefore":0.039739},{"Ticker":"AKAM","EffectiveDate":"2013-10-16","Type":"RatingUpgrade","Title":"DA Davidson upgrades AKAM to Buy from Neutral. Target Price is $62.","DailyReturn":0.009745,"FiveDayReturnAfter":0.039739,"FiveDayReturnBefore":0.025863},{"Ticker":"AKAM","EffectiveDate":"2013-09-27","Type":"RatingNeutral","Title":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $55.","DailyReturn":-0.019329,"FiveDayReturnAfter":-0.030984,"FiveDayReturnBefore":0.000001},{"Ticker":"AKAM","EffectiveDate":"2013-07-24","Type":"EarningsRelease","Title":"AKAM reports 2013 Q2's earning $0.46 per share and revenue $378MM. This meets analyst's estimated EPS $0.46, beats estimated revenue $374.15MM.","DailyReturn":-0.008588,"FiveDayReturnAfter":0.061781,"FiveDayReturnBefore":-0.003836},{"Ticker":"AKAM","EffectiveDate":"2013-07-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.008588,"FiveDayReturnAfter":0.061781,"FiveDayReturnBefore":-0.003836},{"Ticker":"AKAM","EffectiveDate":"2013-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.008588,"FiveDayReturnAfter":0.061781,"FiveDayReturnBefore":-0.003836},{"Ticker":"AKAM","EffectiveDate":"2013-06-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.03078,"FiveDayReturnAfter":0.004688,"FiveDayReturnBefore":0.00094},{"Ticker":"AKAM","EffectiveDate":"2013-06-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.03078,"FiveDayReturnAfter":0.004688,"FiveDayReturnBefore":0.00094},{"Ticker":"AKAM","EffectiveDate":"2013-06-03","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $40.","DailyReturn":-0.004553,"FiveDayReturnAfter":-0.018823,"FiveDayReturnBefore":-0.004974},{"Ticker":"AKAM","EffectiveDate":"2013-05-29","Type":"RatingNeutral","Title":"DA Davidson downgrades AKAM to Neutral from Buy. Target Price is $50.","DailyReturn":-0.004296,"FiveDayReturnAfter":-0.041888,"FiveDayReturnBefore":-0.028164},{"Ticker":"AKAM","EffectiveDate":"2013-05-15","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.024094,"FiveDayReturnAfter":0.00807,"FiveDayReturnBefore":0.038028},{"Ticker":"AKAM","EffectiveDate":"2013-05-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.024094,"FiveDayReturnAfter":0.00807,"FiveDayReturnBefore":0.038028},{"Ticker":"AKAM","EffectiveDate":"2013-05-15","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.024094,"FiveDayReturnAfter":0.00807,"FiveDayReturnBefore":0.038028},{"Ticker":"AKAM","EffectiveDate":"2013-04-30","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on AKAM to Buy. Target Price is $60.","DailyReturn":0.020451,"FiveDayReturnAfter":0.046098,"FiveDayReturnBefore":0.227335},{"Ticker":"AKAM","EffectiveDate":"2013-04-25","Type":"RatingUpgrade","Title":"JP Morgan upgrades AKAM to Overweight from Neutral. Target Price is $52; previously $42.","DailyReturn":0.177057,"FiveDayReturnAfter":0.189958,"FiveDayReturnBefore":0.054376},{"Ticker":"AKAM","EffectiveDate":"2013-04-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.01748,"FiveDayReturnAfter":0.213455,"FiveDayReturnBefore":0.019357},{"Ticker":"AKAM","EffectiveDate":"2013-04-24","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2013 Q1's earning $0.51 per share and revenue $368MM. This beats analyst's estimated EPS $0.47, beats estimated revenue $357.51MM.","DailyReturn":0.01748,"FiveDayReturnAfter":0.213455,"FiveDayReturnBefore":0.019357},{"Ticker":"AKAM","EffectiveDate":"2013-04-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.01748,"FiveDayReturnAfter":0.213455,"FiveDayReturnBefore":0.019357},{"Ticker":"AKAM","EffectiveDate":"2013-04-12","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.010618,"FiveDayReturnAfter":-0.058985,"FiveDayReturnBefore":0.049545},{"Ticker":"AKAM","EffectiveDate":"2013-03-20","Type":"RatingNeutral","Title":"FBN Securities initiates coverage on AKAM to Outperform. Target Price is $45.","DailyReturn":0.022498,"FiveDayReturnAfter":0.011755,"FiveDayReturnBefore":-0.00288},{"Ticker":"AKAM","EffectiveDate":"2013-03-15","Type":"RatingNeutral","Title":"Maxim Group initiates coverage on AKAM to Buy. Target Price is $44.","DailyReturn":0.000866,"FiveDayReturnAfter":0.010048,"FiveDayReturnBefore":-0.072872},{"Ticker":"AKAM","EffectiveDate":"2013-03-01","Type":"RatingNeutral","Title":"Oppenheimer maintains AKAM to Outperform. Target Price is $45; previously $48.","DailyReturn":-0.008387,"FiveDayReturnAfter":0.008621,"FiveDayReturnBefore":-0.002972},{"Ticker":"AKAM","EffectiveDate":"2013-02-25","Type":"RatingUpgrade","Title":"Macquarie upgrades AKAM to Outperform from Neutral. Target Price is $42; previously $41.5.","DailyReturn":0.001103,"FiveDayReturnAfter":0.010423,"FiveDayReturnBefore":-0.04317},{"Ticker":"AKAM","EffectiveDate":"2013-02-07","Type":"RatingNeutral","Title":"Janney Capital downgrades AKAM to Neutral from Buy.","DailyReturn":-0.151996,"FiveDayReturnAfter":-0.108359,"FiveDayReturnBefore":0.028789},{"Ticker":"AKAM","EffectiveDate":"2013-02-07","Type":"RatingNeutral","Title":"Jefferies downgrades AKAM to Hold from Buy. Target Price is $40; previously $44.","DailyReturn":-0.151996,"FiveDayReturnAfter":-0.108359,"FiveDayReturnBefore":0.028789},{"Ticker":"AKAM","EffectiveDate":"2013-02-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.012911,"FiveDayReturnAfter":-0.110926,"FiveDayReturnBefore":0.021421},{"Ticker":"AKAM","EffectiveDate":"2013-02-06","Type":"EarningsBeatRevenueMiss","Title":"After market close, AKAM reports 2012 Q4's earning $0.54 per share and revenue $378MM. This beats analyst's estimated EPS $0.5, misses estimated revenue $381.07MM.","DailyReturn":0.012911,"FiveDayReturnAfter":-0.110926,"FiveDayReturnBefore":0.021421},{"Ticker":"AKAM","EffectiveDate":"2013-02-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.012911,"FiveDayReturnAfter":-0.110926,"FiveDayReturnBefore":0.021421},{"Ticker":"AKAM","EffectiveDate":"2013-01-16","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.007312,"FiveDayReturnAfter":0.010036,"FiveDayReturnBefore":-0.012032},{"Ticker":"AKAM","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Goldman Sachs assumes AKAM to Neutral. Target Price is $44.","DailyReturn":0.009344,"FiveDayReturnAfter":0.033278,"FiveDayReturnBefore":0.095311},{"Ticker":"AKAM","EffectiveDate":"2012-12-11","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.010204,"FiveDayReturnAfter":0.00661,"FiveDayReturnBefore":0.082385},{"Ticker":"AKAM","EffectiveDate":"2012-11-14","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.025613,"FiveDayReturnAfter":-0.018904,"FiveDayReturnBefore":-0.068129},{"Ticker":"AKAM","EffectiveDate":"2012-11-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.025613,"FiveDayReturnAfter":-0.018904,"FiveDayReturnBefore":-0.068129},{"Ticker":"AKAM","EffectiveDate":"2012-10-25","Type":"RatingUpgrade","Title":"Canaccord Genuity upgrades AKAM to Buy from Hold. Target Price is $45; previously $38.","DailyReturn":0.067294,"FiveDayReturnAfter":0.058357,"FiveDayReturnBefore":-0.050491},{"Ticker":"AKAM","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Buy. Target Price is $44; previously $43.","DailyReturn":0.067294,"FiveDayReturnAfter":0.058357,"FiveDayReturnBefore":-0.050491},{"Ticker":"AKAM","EffectiveDate":"2012-10-25","Type":"RatingUpgrade","Title":"Oppenheimer upgrades AKAM to Outperform from Perform. Target Price is $50.","DailyReturn":0.067294,"FiveDayReturnAfter":0.058357,"FiveDayReturnBefore":-0.050491},{"Ticker":"AKAM","EffectiveDate":"2012-10-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010414,"FiveDayReturnAfter":0.055435,"FiveDayReturnBefore":-0.059577},{"Ticker":"AKAM","EffectiveDate":"2012-10-24","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2012 Q3's earning $0.43 per share and revenue $345MM. This beats analyst's estimated EPS $0.41, beats estimated revenue $338.2MM.","DailyReturn":-0.010414,"FiveDayReturnAfter":0.055435,"FiveDayReturnBefore":-0.059577},{"Ticker":"AKAM","EffectiveDate":"2012-10-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.010414,"FiveDayReturnAfter":0.055435,"FiveDayReturnBefore":-0.059577},{"Ticker":"AKAM","EffectiveDate":"2012-08-29","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Hold. Target Price is $37; previously $34.","DailyReturn":0.009917,"FiveDayReturnAfter":0.010663,"FiveDayReturnBefore":-0.00321},{"Ticker":"AKAM","EffectiveDate":"2012-07-26","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Hold. Target Price is $34; previously $32.","DailyReturn":0.240354,"FiveDayReturnAfter":0.217962,"FiveDayReturnBefore":-0.057433},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.004931,"FiveDayReturnAfter":0.214441,"FiveDayReturnBefore":-0.062798},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.004931,"FiveDayReturnAfter":0.214441,"FiveDayReturnBefore":-0.062798},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"EarningsRevenueBeat","Title":"AKAM reports 2012 Q2's earning $0.43 per share and revenue $331MM. This beats analyst's estimated EPS $0.37, beats estimated revenue $325.74MM.","DailyReturn":-0.004931,"FiveDayReturnAfter":0.214441,"FiveDayReturnBefore":-0.062798},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.004931,"FiveDayReturnAfter":0.214441,"FiveDayReturnBefore":-0.062798},{"Ticker":"AKAM","EffectiveDate":"2012-07-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010255,"FiveDayReturnAfter":-0.062798,"FiveDayReturnBefore":0.01735},{"Ticker":"AKAM","EffectiveDate":"2012-07-18","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.010255,"FiveDayReturnAfter":-0.062798,"FiveDayReturnBefore":0.01735},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.033786,"FiveDayReturnAfter":-0.034027,"FiveDayReturnBefore":-0.066938},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"RatingUpgrade","Title":"Citigroup upgrades AKAM to Neutral from Sell. Target Price is $32.","DailyReturn":-0.033786,"FiveDayReturnAfter":-0.034027,"FiveDayReturnBefore":-0.066938},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Hold. Target Price is $32; previously $34.","DailyReturn":-0.033786,"FiveDayReturnAfter":-0.034027,"FiveDayReturnBefore":-0.066938},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.033786,"FiveDayReturnAfter":-0.034027,"FiveDayReturnBefore":-0.066938},{"Ticker":"AKAM","EffectiveDate":"2012-05-01","Type":"EarningsRelease","Title":"After market close, AKAM reports 2012 Q1's earning $0.24 per share and revenue $319.448MM..","DailyReturn":0.031298,"FiveDayReturnAfter":-0.009559,"FiveDayReturnBefore":-0.156209},{"Ticker":"AKAM","EffectiveDate":"2012-04-26","Type":"RatingUpgrade","Title":"Jefferies upgrades AKAM to Buy from Hold. Target Price is $42; previously $41.","DailyReturn":-0.144516,"FiveDayReturnAfter":-0.128127,"FiveDayReturnBefore":0.008812},{"Ticker":"AKAM","EffectiveDate":"2012-04-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.026762,"FiveDayReturnAfter":-0.115897,"FiveDayReturnBefore":0.002918},{"Ticker":"AKAM","EffectiveDate":"2012-04-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.026762,"FiveDayReturnAfter":-0.115897,"FiveDayReturnBefore":0.002918},{"Ticker":"AKAM","EffectiveDate":"2012-04-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.026762,"FiveDayReturnAfter":-0.115897,"FiveDayReturnBefore":0.002918},{"Ticker":"AKAM","EffectiveDate":"2012-04-04","Type":"RatingUpgrade","Title":"DA Davidson upgrades AKAM to Buy from Neutral. Target Price is $45; previously $40.","DailyReturn":0.002749,"FiveDayReturnAfter":-0.011055,"FiveDayReturnBefore":-0.035111},{"Ticker":"AKAM","EffectiveDate":"2012-03-14","Type":"RatingNeutral","Title":"Oxen Group initiates coverage on AKAM to Hold. Target Price is $44.","DailyReturn":-0.021617,"FiveDayReturnAfter":-0.019401,"FiveDayReturnBefore":0.071915},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"PiperJaffray maintains AKAM to Neutral. Target Price is $36; previously $26.","DailyReturn":0.10511,"FiveDayReturnAfter":0.099944,"FiveDayReturnBefore":0.073172},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $41; previously $36.","DailyReturn":0.10511,"FiveDayReturnAfter":0.099944,"FiveDayReturnBefore":0.073172},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"DA Davidson maintains AKAM to Neutral. Target Price is $40; previously $36.","DailyReturn":0.10511,"FiveDayReturnAfter":0.099944,"FiveDayReturnBefore":0.073172},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains AKAM to Buy. Target Price is $43; previously $32.","DailyReturn":0.10511,"FiveDayReturnAfter":0.099944,"FiveDayReturnBefore":0.073172}];